Platelets Flashcards
Glanzmann’s thrombasthenia
absence of the platelet Gp IIb/IIIa receptor
Glanzmann’s thrombasthenia (absence of the platelet Gp IIb/IIIa receptor) and Bernard- Soulier syndrome (absence of the platelet Gp Ib-IX-V receptor).
Both are inherited in an autosomal recessive fashion and present with bleeding symptoms in childhood.
Bernard- Soulier syndrome
absence of the platelet Gp Ib-IX-V receptor
Glanzmann’s thrombasthenia (absence of the platelet Gp IIb/IIIa receptor) and Bernard- Soulier syndrome (absence of the platelet Gp Ib-IX-V receptor). Both are inherited in an autosomal recessive fashion and present with bleeding symptoms in childhood.
Platelet storage pool disorder (SPD)
- what is it?
- inheritance pattern
- what causes it
- how it appears
Platelet storage pool disorder (SPD): a “secretion defect”
- the classic autosomal dominant qualitative platelet disorder.
- abnormalities of platelet granule formation.
- It is also seen as a part of inherited disorders of granule formation, such as Hermansky-Pudlak syndrome.
- Bleeding symptoms in SPD variable but often mild.
The most common inherited disorders of platelet function prevent normal secretion of granule content and are termed secretion defects. Few of these abnormalities have been dissected at the molecular level but they likely result from various mutations.
Hermansky-Pudlak syndrome
latelet storage pool disorder (SPD) is the classic autosomal dominant qualitative platelet disorder. This results from abnormalities of platelet granule formation. It is also seen as a part of inherited disorders of granule formation such as Hermansky-Pudlak syndrome.
Bleeding symptoms in SPD are variable, but often are mild. The most common inherited disorders of platelet function prevent normal secretion of granule content and are termed secretion defects. Few of these abnormalities have been dissected at the molecular level but they likely result from various mutations.
Platelet disorders associated with milder bleeding symptoms frequently respond to
desmopressin
DDAVP
DDAVP increases plasma VWF and factor VIII levels
it may also have a direct effect on platelet function
Particularly for mucosal bleeding symptoms, antifibrinolytic therapy (ε- aminocaproic acid or tranexamic acid) is used alone or in conjunction with DDAVP or platelet therapy.
DDAVP
- DDAVP increases plasma VWF and factor VIII levels
- it may also have a direct effect on platelet function.
- Particularly for mucosal bleeding symptoms–> antifibrinolytic therapy (ε- aminocaproic acid or tranexamic acid) is used alone or in conjunction with DDAVP or platelet therapy.
DDAVP might be used with what else?
antifibrinolytic therapy (ε- aminocaproic acid or tranexamic acid) is used alone or in conjunction with DDAVP or platelet therapy.
Acquired platelet dysfunction is usually due to
Acquired platelet dysfunction occurs in ____
Acquired platelet dysfunction is usually due to medications
- intentionally: as with antiplatelet therapy
- unintentionally: as with high-dose penicillins.
Acquired platelet dysfunction occurs in uremia.
how do we treat platelet defects arising from uremia?
Acquired platelet dysfunction occurs in uremia. This is likely multifactorial, but the resultant effect is defective adhesion and activation. The platelet defect is improved most by dialysis but may also be improved by
- increasing the hematocrit to 27–32%
- giving DDAVP (0.3 μg/kg)
- use of conjugated estrogens.
Platelet dysfunction also occurs with cardiopulmonary bypass due to the effect of the artificial circuit on platelets, and bleeding symptoms respond to platelet transfusion.
Glanzmann Thrombasthenia: Ristocetin
Glanzmann Thrombasthenia:
- (+) Ristocetin (positive aggregation)
- No aggregation to everything else
Bernard Soulier Syndrome: Ristocetin test
Bernard Soulier Syndrome (-)
- Ristocetin (absent aggregation)
- Normal to everything else (ADP, collagen, arachidonic acid, epinephrine)
vW disease: ristocetin test
vW disease:
- (-) Ristocetin (absent aggregation)
- Tx: Cryoprecipitate - replaces vWF
- DDAVP (Desmopressin) → causes release of vWF from endothelium